“…The use of IV antibiotics remains controversial, primarily because the majority of antibiotics do not achieve therapeutic levels in the vitreous, even in inflamed aphakic eyes in which increased vascular permeability allows for better penetration [2,4,8,13,23,24,25,28,29,20]. The few exceptions to that rule are ciprofloxacin [10], cefazolin [17], ceftazidime [2], vancomycin [1,18], and imipenem [3], which have been demonstrated to achieve adequate levels in animal models of aphakic inflamed eyes.…”